We are live on ! Find out more
GKIM

GW&K Investment Management Portfolio holdings

AUM $11.3B
1-Year Est. Return 31.98%
This Fund
S&P 500
This Quarter Est. Return
+5.42%
1 Year Est. Return
+31.98%
3 Year Est. Return
+79.76%
5 Year Est. Return
+101.81%
10 Year Est. Return
+512.72%
AUM
$5.85B
AUM Growth
-$145M
Cap. Flow
-$400M
Cap. Flow %
-6.83%
Top 10 Hldgs %
13.17%
Holding
280
New
19
Increased
117
Reduced
131
Closed
11

Sector Composition

Rank Sector Weight
1 Technology 16.99%
2 Industrials 15.29%
3 Financials 13.49%
4 Healthcare 12.83%
5 Consumer Discretionary 12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RPM icon
51
RPM International
RPM
$15B
$37.3M 0.64%
712,403
-96,663
-12% -$5.06M
ZBRA icon
52
Zebra Technologies
ZBRA
$17.8B
$37.3M 0.64%
358,988
+16,047
+5% +$1.74M
SF
53
Stifel
SF
$12.6B
$37.1M 0.63%
1,400,848
-185,152
-12% -$4.53M
SBNY
54
DELISTED
Signature Bank
SBNY
$36.1M 0.62%
262,816
-16,145
-6% -$2.13M
QTS
55
DELISTED
QTS REALTY TRUST, INC.
QTS
$36M 0.61%
663,777
+209,816
+46% +$11.7M
HCSG icon
56
Healthcare Services Group
HCSG
$1.53B
$35.9M 0.61%
680,922
-128,427
-16% -$6.73M
CVA
57
DELISTED
Covanta Holding Corporation
CVA
$35.6M 0.61%
2,107,721
-128,188
-6% -$1.98M
EXPO icon
58
Exponent
EXPO
$3.24B
$35.3M 0.6%
993,714
+150,554
+18% +$5.53M
AMGN icon
59
Amgen
AMGN
$222B
$35.2M 0.6%
+202,307
New +$35.8M
WSO icon
60
Watsco Inc
WSO
$13.6B
$34.4M 0.59%
202,321
-2,524
-1% -$417K
ENB icon
61
Enbridge
ENB
$112B
$33.6M 0.57%
857,882
-125,295
-13% -$4.82M
CMD
62
DELISTED
Cantel Medical Corporation
CMD
$33.4M 0.57%
324,579
-60,796
-16% -$6.06M
NWE icon
63
NorthWestern Energy
NWE
$4.43B
$33.2M 0.57%
555,406
-102,095
-16% -$6.15M
PFGC icon
64
Performance Food Group
PFGC
$18B
$33M 0.56%
997,300
+114,366
+13% +$3.35M
ORI icon
65
Old Republic International
ORI
$10.4B
$32.6M 0.56%
1,526,957
-19,712
-1% -$403K
ANSS
66
DELISTED
Ansys
ANSS
$32.4M 0.55%
219,462
-39,526
-15% -$5.6M
HAS icon
67
Hasbro
HAS
$13.2B
$32.1M 0.55%
352,973
+48,957
+16% +$4.59M
EXLS icon
68
EXL Service
EXLS
$5.29B
$31.5M 0.54%
2,607,315
-311,485
-11% -$3.8M
CALD
69
DELISTED
Callidus Software, Inc.
CALD
$31.5M 0.54%
1,097,903
-102,256
-9% -$2.79M
GSK icon
70
GSK
GSK
$106B
$31.3M 0.53%
705,622
-122,004
-15% -$5.64M
JBTM
71
JBT Marel
JBTM
$6.39B
$31.1M 0.53%
280,903
-111,365
-28% -$12.2M
BCPC
72
Balchem Corp
BCPC
$5.72B
$31.1M 0.53%
385,297
-25,889
-6% -$2.16M
WAGE
73
DELISTED
WageWorks, Inc.
WAGE
$31M 0.53%
500,198
+37,969
+8% +$2.38M
IPXL
74
DELISTED
Impax Laboratories, Inc.
IPXL
$31M 0.53%
1,859,924
+1,108,348
+147% +$20.3M
CSGP icon
75
CoStar Group
CSGP
$12.3B
$30.8M 0.53%
1,035,980
+2,770
+0.3% +$81.2K

Similar funds

GW&K Investment Management's Q4 2017 Portfolio in Review

As of Q4 2017, GW&K Investment Management held 280 positions worth $5.85B, down 2.4% from $6B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

GW&K Investment Management withdrew a net $400M in Q4 2017, closing 11 positions and reducing 131 holdings. Its most notable exit was Syneos Health, Inc. Class A Common Stock, an estimated $43.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Financials.

Against the trend, GW&K Investment Management opened a new position in Amgen worth $35.2M.

  • GW&K Investment Management's largest Q4 2017 buy was Amgen: 202,307 shares worth $35.2M.
  • GW&K Investment Management added most to Impax Laboratories, Inc. in Q4 2017, an estimated $20.3M increase.
  • GW&K Investment Management's biggest Q4 2017 reduction was Sun Communities, cutting an estimated $33.2M.
  • GW&K Investment Management fully exited Syneos Health, Inc. Class A Common Stock in Q4 2017, selling an estimated $43.9M.
  • GW&K Investment Management's ten largest holdings make up 13% of its $5.85B portfolio in Q4 2017.
  • GW&K Investment Management opened 19 new positions and closed 11 in Q4 2017.
  • GW&K Investment Management's portfolio value fell 2.4% quarter-over-quarter to $5.85B.

Based on GW&K Investment Management's 13F filing for Q4 2017, filed 19 Jan 2018.